These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8743)

  • 1. Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations.
    Ban TA
    Neuropsychobiology; 1975; 1(3):133-45. PubMed ID: 8743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative findings with nicotinic acid in the treatment of schizophrenias.
    Ban TA
    Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
    Ananth JV; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217
    [No Abstract]   [Full Text] [Related]  

  • 5. On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias.
    Ban TA
    Psychopharmacol Bull; 1969 Jul; 5(3):5-20. PubMed ID: 4906584
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
    Petrie WM; Ban TA; Ananth JV
    Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megavitamin B-3 therapy for schizophrenia.
    Hoffer A
    Can Psychiatr Assoc J; 1971 Dec; 16(6):499-504. PubMed ID: 4947171
    [No Abstract]   [Full Text] [Related]  

  • 8. Megavitamin and orthomolecular therapy in psychiatry.
    Nutr Rev; 1974 Jul; 32(0):suppl 1:44-7. PubMed ID: 4367658
    [No Abstract]   [Full Text] [Related]  

  • 9. Pigmented hyperkeratosis among schizophrenic patients treated with nicotinic acid.
    Wittenborn JR; Nenno R; Rothberg H; Shelley WB
    Adv Biochem Psychopharmacol; 1974; 9(0):295-300. PubMed ID: 4151765
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicotinic acid therapy in chronic schizophrenia.
    Sehdev HS; Olson JL
    Compr Psychiatry; 1974; 15(6):511-7. PubMed ID: 4609684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical treatment possibilities in psychoses].
    Kanig K; Oesterle W
    Med Welt; 1969 Sep; 36():1938-45. PubMed ID: 4241466
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.
    Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J
    Can Med Assoc J; 1970 May; 102(9):939-42. PubMed ID: 4157149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: NAD and chronic schizophrenia.
    Altus MS
    Am J Psychiatry; 1974 Sep; 131(9):1043-4. PubMed ID: 4370155
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with the neuroleptic 19.366 R.P. (pipothiazine)].
    Arrojo Lois M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):309-12. PubMed ID: 31067
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
    Deutsch M; Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinic acid in the treatment of schizophrenias.
    Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1970 Oct; 15(5):499-500. PubMed ID: 5492190
    [No Abstract]   [Full Text] [Related]  

  • 19. A search for responders to niacin supplementation.
    Wittenborn JR
    Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.